Attached files

file filename
EX-31.1 - SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER. - SCIVANTA MEDICAL CORPf10q0112ex31i_scivantamedic.htm
EX-31.2 - SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER. - SCIVANTA MEDICAL CORPf10q0112ex31ii_scivantamedic.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350. - SCIVANTA MEDICAL CORPf10q0112ex32ii_scivantamedic.htm
EXCEL - IDEA: XBRL DOCUMENT - SCIVANTA MEDICAL CORPFinancial_Report.xls
10-Q - QUARTERLY REPORT - SCIVANTA MEDICAL CORPf10q0112_scivantamedic.htm
EX-4.4 - FORM OF ADDENDUM TO CONVERTIBLE DEBENTURE, DATED AS OF JANUARY 31, 2012, ISSUED TO CERTAIN PERSONS SET FORTH IN EXHIBIT 4.2. - SCIVANTA MEDICAL CORPf10q01124iv_scivantamedic.htm
EXHIBIT 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
 
PURSUANT TO 18 U.S.C. SECTION 1350,
 
AS ADOPTED PURSUANT TO
 
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report of Scivanta Medical Corporation (the “Company”) on Form 10-Q for the period ended January 31, 2012, as filed with the Securities and Exchange Commission (the “Report”), I, David R. LaVance, President and Chief Executive Officer of the Company, do hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
 
(1)           the Report fully complies with the requirements of §13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, 15 U.S.C. §78m or 78o(d), and,
 
(2)           the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date:  March 16, 2012
By:
/s/ David R. LaVance  
    David R. LaVance  
    President and Chief Executive Officer